Loading clinical trials...
Loading clinical trials...
To facilitate clinical, basic science, and translational research projects involving the study of rheumatic diseases.
A rheumatology biorepository will be created to permit comparative analyses between the rheumatic diseases in order to increase the understanding of disease pathogenesis. Patients seen at Yale clinics diagnosed with rheumatic diseases are invited to participate in this study. These rheumatic diseases include, but are not limited to: adult onset Still's disease, ankylosing spondylitis, psoriatic arthritis, reactive arthritis, antiphospholipid syndrome, systemic lupus erythematosus, Behcet's disease, dermatomyositis, polymyositis, giant cell arteritis and other vasculitides, Lyme's disease, mixed connective tissue disease, polymyalgia rheumatica, rheumatoid arthritis, sarcoidosis, systemic sclerosis (scleroderma), Sjogren's syndrome, and undifferentiated connective tissue disease.
Age
18 - 99 years
Sex
ALL
Healthy Volunteers
Yes
Yale New Haven Hospital
New Haven, Connecticut, United States
Start Date
August 4, 2020
Primary Completion Date
June 1, 2030
Completion Date
June 1, 2030
Last Updated
February 13, 2026
5,000
ESTIMATED participants
Lead Sponsor
Yale University
Collaborators
NCT07469787
NCT07261644
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT04751396